Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression.

Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2010 Feb;18(2):128-35. doi: 10.1097/JGP.0b013e3181c796d2.

2.

Change in cognitive functioning following acute antidepressant treatment in late-life depression.

Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2009 Oct;17(10):881-8.

3.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
4.

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

Feighner JP, Overø K.

J Clin Psychiatry. 1999 Dec;60(12):824-30.

PMID:
10665628
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
6.

Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?

Barak Y, Kimhi R, Weizman R.

Int Clin Psychopharmacol. 2000 Jan;15(1):53-6.

PMID:
10836288
7.

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.

Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H; Old-Old Depression Study Group.

Am J Psychiatry. 2004 Nov;161(11):2050-9.

PMID:
15514406
8.
9.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
10.
11.
12.

Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

Kasckow J, Lanouette N, Patterson T, Fellows I, Golshan S, Solorzano E, Zisook S.

Int J Geriatr Psychiatry. 2010 Feb;25(2):183-90. doi: 10.1002/gps.2318.

13.

Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M.

Eur J Pain. 2005 Feb;9(1):33-8.

PMID:
15629872
14.
15.
16.

Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.

Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E, Taricco B, Bogetto F.

J Clin Psychiatry. 2005 Mar;66(3):360-9.

PMID:
15766303
17.

Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.

Alexopoulos GS, Manning K, Kanellopoulos D, McGovern A, Seirup JK, Banerjee S, Gunning F.

Psychol Med. 2015 Oct;45(14):3111-20. doi: 10.1017/S0033291715001075. Epub 2015 Jul 14.

18.

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

Lepola UM, Loft H, Reines EH.

Int Clin Psychopharmacol. 2003 Jul;18(4):211-7.

PMID:
12817155
19.

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.

Wade A, Michael Lemming O, Bang Hedegaard K.

Int Clin Psychopharmacol. 2002 May;17(3):95-102.

PMID:
11981349
20.

Supplemental Content

Support Center